Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.

Not yet recruitingOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 25, 2027

Study Completion Date

September 15, 2028

Conditions
CardiotoxicityDPP3HSCTAllogeneic Hematopoietic Stem Cell TransplantationACS - Acute Coronary SyndromeCardiac DysfunctionArrythmia, CardiacPulmonary HypertensionMachine Learning
All Listed Sponsors
collaborator

INSERM UMR-S 942 MASCOT

UNKNOWN

collaborator

INSERM U1086 Cancers et Préventions

UNKNOWN

collaborator

Fédération Française de Cardiologie

OTHER

lead

Assistance Publique - Hôpitaux de Paris

OTHER